TRPV2 is expressed in several cell types and is required for directional migration of macrophages (Link et al., 2010), prostate tumours (Monet et al., 2010), bladder cancer (Liu and Wang, 2013) and oesophageal squamous cell carcinoma (Kudou et al., 2019). Here, TRPV2 is linked to prostate neoplasm.